Medicare Enrolled
Dr. Boris Shwartzman, M.D.
Anesthesiology · Attleboro, MA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Shwartzman from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Shwartzman?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Shwartzman
Dr. Boris Shwartzman is an anesthesiology specialist in Attleboro, MA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Shwartzman performed 5,486 Medicare services across 2,305 unique beneficiaries.
Between the years covered by Open Payments, Dr. Shwartzman received a total of $13,424 from 57 pharmaceutical and/or device companies across 315 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in anesthesiology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Shwartzman is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 1% volume in MA
$13,424 industry payments
Medicare Practice Summary
Medicare Utilization ↗5,486
Medicare services
Top 1% in MA for anesthesiology
2,305
Unique beneficiaries
$82
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~274 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Drug screening test A laboratory test that uses a chemistry analyzer to detect the presence of drugs in a sample. |
1,422 | $60 | $200 |
| Steroid injection (triamcinolone) A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered. |
1,394 | $1 | $10 |
| Definitive drug test using GC/MS or LC/MS A definitive drug test that identifies specific drugs and distinguishes between structural isomers using advanced methods like GC/MS or LC/MS. |
1,272 | $152 | $368 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
664 | $101 | $360 |
| Injection into lower spine canal with imaging guidance A procedure where a substance is injected into the lower part of the spinal canal. The injection is performed using imaging guidance to ensure accurate placement. |
158 | $221 | $1,223 |
| Definitive drug test using GC/MS or LC/MS A definitive drug test that identifies specific drugs and distinguishes between structural isomers using advanced methods like GC/MS or LC/MS. |
111 | $189 | $486 |
| Contrast dye for imaging, lower concentration | 74 | $0 | $5 |
| Injection, propofol, 10 mg | 66 | $0 | $17 |
| Sacral spine nerve root injection with imaging guidance An injection of anesthetic and/or steroid medication into a sacral spine nerve root. The procedure uses imaging guidance to ensure accurate placement. |
39 | $206 | $1,443 |
| Additional sacral spine nerve root injection with imaging An injection of anesthetic and/or steroid medication into an additional sacral spine nerve root level, guided by imaging. |
36 | $93 | $677 |
| Spinal injection with imaging guidance A procedure where medication is injected into the middle or upper part of the spinal canal. Imaging technology is used to guide the needle to the correct location. |
31 | $229 | $1,361 |
| New patient office visit, complex (60-74 min) | 30 | $180 | $666 |
| Fluoroscopic guidance for needle placement Use of real-time X-ray imaging to guide the precise placement of a needle during a medical procedure. |
21 | $101 | $328 |
| Telephone medical discussion, 21-30 minutes A telephone conversation with a physician lasting between 21 and 30 minutes. This code covers the time spent discussing medical matters over the phone. |
21 | $105 | $403 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
20 | $104 | $557 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
20 | $71 | $285 |
| Joint injection, major joint Removal of fluid from a large joint and/or injection of medication into the joint space. |
18 | $56 | $371 |
| Spine facet joint injection with imaging guidance, single level An injection is administered into a single facet joint of the lower or sacral spine while using imaging guidance to ensure accurate placement. |
18 | $205 | $1,998 |
| Facet joint injection, second level, with imaging guidance An injection into a lower or sacral spine facet joint using imaging guidance for the second level treated. |
18 | $104 | $787 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
17 | $61 | $246 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
13 | $19 | $98 |
| Heat destruction of intraosseous basivertebral nerve in bones of spine in lower back, first two bones | 12 | $366 | $5,182 |
| Spinal stabilization device placement Surgical procedure to stabilize a fractured vertebra in the lower spine by inserting a supportive device. |
11 | $380 | $26,000 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$13,424
Total received (2018-2024)
Avg $1,918/year across 7 years
Top 5% in MA for anesthesiology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
57
Companies
315
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$11,051 (82.3%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$2,153 (16.0%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$220 (1.6%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$3,146
2023
$3,582
2022
$3,593
2021
$999
2020
$286
2019
$792
2018
$1,024
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Spinal Simplicity, LLC
$2,153
Saluda Medical Americas, Inc.
$186
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$155
PAINTEQ LLC
$122
Curonix LLC
$98
Boston Scientific Corporation
$81
ABBVIE INC.
$73
Vertos Medical, Inc.
$48
Valinor Pharma, LLC
$46
Abbott Laboratories
$41
Lundbeck LLC
$29
Averitas Pharma Inc.
$26
SCILEX PHARMACEUTICALS INC.
$24
Novo Nordisk Inc
$24
PFIZER INC.
$22
Nevro Corp.
$20
Top 3 companies account for 79.3% of 2024 payments
All-time payments by company (2018-2024) ›
Spinal Simplicity, LLC
$3,670
Medtronic, Inc.
$2,568
Relievant Medsystems, Inc.
$1,230
Boston Scientific Corporation
$621
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$556
Abbott Laboratories
$437
Nevro Corp.
$398
Collegium Pharmaceutical, Inc.
$327
PFIZER INC.
$286
Vertos Medical, Inc.
$273
Scilex Pharmaceuticals Inc.
$270
AbbVie Inc.
$230
Saluda Medical Americas, Inc.
$186
BioDelivery Sciences International, Inc.
$162
PAINTEQ LLC
$155
Bioventus LLC
$138
Valinor Pharma, LLC
$116
Curonix LLC
$116
Stimwave Technologies Incorporated
$106
Daiichi Sankyo Inc.
$99
Biohaven Pharmaceutical Holding Company Ltd.
$97
Fidia Pharma USA Inc.
$94
ARBOR PHARMACEUTICALS, INC.
$78
ABBVIE INC.
$73
Lilly USA, LLC
$72
Medtronic USA, Inc.
$68
Flexion Therapeutics, Inc.
$66
Merz Pharmaceuticals, LLC
$61
Kaleo, Inc.
$58
Averitas Pharma Inc.
$57
GRT US Holding, Inc.
$50
DePuy Synthes Sales Inc.
$48
Teva Pharmaceuticals USA, Inc.
$44
BOSTON SCIENTIFIC CORPORATION
$44
Zyla Life Sciences
$40
Purdue Pharma L.P.
$40
Electronic Waveform Lab, Inc.
$39
Flowonix Medical Incorporated
$34
FIDIA PHARMA USA INC.
$34
Egalet US Inc
$34
SPR Therapeutics, Inc
$32
Ipsen Biopharmaceuticals, Inc
$30
Lundbeck LLC
$29
Shionogi Inc
$26
SCILEX PHARMACEUTICALS INC.
$24
Novo Nordisk Inc
$24
Hikma Pharmaceuticals USA
$23
RedHill Biopharma Inc.
$23
Stryker Corporation
$22
Biohaven Pharmaceuticals, Inc.
$18
BIODELIVERY SCIENCES INTERNATIONAL, INC.
$17
Indivior Inc.
$15
Pernix Therapeutics Holdings, Inc.
$14
Ultragenyx Pharmaceutical Inc.
$14
Alkermes, Inc.
$13
IBSA Pharma Inc.
$13
Zyla Life Sciences, Inc.
$12
Top 3 companies account for 55.6% of all-time payments
Associated products mentioned in payments ›
AJOVY · BELBUCA · BOTOX · BUNAVAIL 2.1 mg 30-count box · Crysvita · Durolane · Dysport · EMBEDA · EMGALITY · ETERNA · EVZIO · Evoke · Evzio · FLECTOR PATCH · GENERAL PAIN MANAGEMENT · HA MINUTEMAN G3-R · HYMOVIS · Horizant · Hymovis · INTELLIS · INTELLIS ADAPTIVESTIM · IONICRF · Intracept · KYPHON EXPRESS II KYPHOPAK TRAY · Kloxxado · LYRICA · MONOVISC · MOVANTIK · Morphabond ER · Movantik · NURTEC ODT · OCTRODE · ORTHOVISC · PAINTEQ · PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A · PROCLAIM · Penta SCS Leads · Prometra II · QULIPTA · QUTENZA · Qutenza · RELISTOR · RELISTOR ORAL · REYVOW · SPECTRA WAVEWRITER · SPINEJACK · SPRINT PNS System · SPRIX · SUBLOCADE · SYMPROIC · SYNCHROMED · SYNCHROMEDII · Senza · Senza Spinal Cord Stimulation System · StimQ Receiver Stimulator Kit Channel A US w Receiver · Stimrouter Implantable Kit · Superion · Superion Indirect Decompression System · Symproic · Tirosint · UBRELVY · V-LOC 180 · VANTA ADAPTIVESTIM · VYEPTI · Vivitrol 380 mg · WaveWriter Alpha Prime 16 · XTAMPZA · XTAMPZAER · Xeomin · Xtampza ER · ZOHYDRO ER · ZTLido · ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH · Zilretta · mild Device Kit
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (82%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 5% for anesthesiology in MA.
Geographic Context
Anesthesiologists within 10 mi
332
Per 100K population
57.4
County median income
$84,198
Nearest hospital
STURDY MEMORIAL HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Shwartzman is a mixed practice specialist, with above-average Medicare volume (top 1% in MA), with low-engagement industry engagement in the top 5% of MA peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Shwartzman experienced with drug screening test?
Based on Medicare claims data, Dr. Shwartzman performed 1,422 drug screening test services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Shwartzman receive payments from pharmaceutical companies?
Yes. Dr. Shwartzman received a total of $13,424 from 57 companies across 315 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Shwartzman's costs compare to other anesthesiologists in Attleboro?
Dr. Shwartzman's average Medicare payment per service is $82. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Shwartzman) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Anesthesiologists in Attleboro
Browse anesthesiologists in Attleboro ranked by procedure volume and transparency data.
Highest volume
Top Anesthesiologists in MA
Anesthesiologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Anesthesiologists in MA
Which MA anesthesiologists receive the most from drug and device companies.
By company
Spinal Simplicity, LLC Payments to Doctors
See all physicians who received payments from Spinal Simplicity, LLC.
By company
Medtronic, Inc. Payments to Doctors
See all physicians who received payments from Medtronic, Inc.
By company
Relievant Medsystems, Inc. Payments to Doctors
See all physicians who received payments from Relievant Medsystems, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology